| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5929158 | American Heart Journal | 2010 | 7 Pages |
Abstract
ST2 levels are elevated early in NSTE-ACS and predict 1-year mortality. Our data indicate that ST2 represents an interesting novel pathophysiologic pathway in the setting of ischemia-related myocardial dysfunction. However, future prospective evaluations in larger populations are needed before the clinical utility of ST2 can be determined.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kai M. MD, PhD, Paul W. MD, Robert M. MD, Maarten L. MD, PhD, Per MD, PhD, Lars MD, PhD, Stefan K. MD, PhD,